RYHIX Rating, Research - Rydex Health Care Inv

Rydex Health Care Inv (ryhix)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New Mutual Fund | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 60

Threats + Weaknesses = 39

When strengths & opportunities substantially exceed threats & weaknesses an investment in the ryhix mutual fund has great long term potential.

Fund Management Team

Fund Description Update

Rydex Health Care Inv (RYHIX) Description: RYHIX is a mutual fund, which is an investment that owns a basket of assets. The RYHIX mutual fund was provided by Rydex and this investment vehicle derives the majority of its value from equity holdings (stocks). Rydexs mutual fund has a long management tenure and is in the small fund size classification. RYHIXs minimum initial investment amount is $2500 while the IRA minimum is $1000. RYHIXs expense ratio is roughly 1%. The latest RYHIXs front end load was 0% and the back end load was 0%. The Rydex Health Care Inv (RYHIX) mutual fund falls under the health category. RYHIX focuses its investments in USA and RYHIX is focused on the health industry or fund sector. The Rydex Health Care Inv (RYHIX) mutual fund is not a leveraged fund and it does not have inverse fund properties. An investor can find RYHIXs top holdings, fundamental analysis, ratings, and fund risk (volatility) on the left side of the screen. The right side of RYHIXs research report features technical analysis and long term investment potential.

Portfolio Strategy Update

This investment vehicle seeks capital appreciation. The fund invests substantially at least 80% of its net assets in equity securities (see equity research) of Health Care Companies that are traded in the United States and derivatives. Health Care Companies include pharmaceutical companies, companies involved in the research and development of pharmaceutical products and services, companies involved in the operation of health care facilities, and other companies involved in the design, manufacture, or sale of health care-related products or services. It is non-diversified.

Management Analysis Update

Performance Analysis Update